Has Henry Bell, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,255 in general payments to Henry Bell, MD across 19 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Henry Bell, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Henry Bell, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Henry Bell, MD

Anatomic Pathology & Clinical Pathology · Columbia, MDNPI 1457326555

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,056 of the $1,255 with a category attached, or 84.2%. 6 manufacturers reported payments, led by Johnson & Johnson at 34.4% of the total. Reporting peaked in 2024 at $533 and has fallen 76.3% since, to $127 in 2025.

$1,255in general payments, 2019–2025

Across 19 payments — averaging $66.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$431
Abbott$322
Boston Scientific$307
E.r. Squibb & Sons, L.L.C.$135
Roche Diagnostics Corporation$41
Meridian Bioscience Inc.$19

What the payments were for

Travel & lodging$19816%
Food & beverage$1,05684%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	4	$431
Abbott	6	$322
Boston Scientific	4	$307
E.r. Squibb & Sons, L.L.C.	1	$135
Roche Diagnostics Corporation	2	$41
Meridian Bioscience Inc.	2	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,255 in reported general payments places this provider in the 80th percentile of 186 anatomic pathology & clinical pathology providers in Maryland.

See all anatomic pathology & clinical pathology providers in Maryland →

Medicare billing

Part B allowed, 2024

$755,926

Medicare patients

1,730

Services billed

7,782

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Columbia

Lola HooverColumbia$858
Arash MohtashamianBethesda$390K
Aatur SinghiBaltimore$133K
Brigitte RonnettBaltimore$112K
Robert KurmanBaltimore$110K
Robert AndersBaltimore$92K
Mark LowryBethesda$84K
Kelly Brenan RothschildBaltimore$67K
Edward McCarthyBaltimore$63K
Jonathan EpsteinBaltimore$33K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →